Taiwan Life Insurance Receives Regulatory Approval to Invest in The Resolute Fund VII, L.P.
Original: 代台灣人壽公告核准投資 The Resolute Fund VII, L.P.
Summary
CTBC Financial is disclosing, on behalf of its subsidiary Taiwan Life Insurance (台灣人壽), that regulatory approval has been granted for Taiwan Life to make an investment in The Resolute Fund VII, L.P., a private limited partnership. This type of filing typically indicates the Financial Supervisory Commission (FSC) or relevant authority has cleared the alternative investment allocation under insurance investment regulations. The investment size, terms, and expected return have not been disclosed in the subject line; full details are available on MOPS.
Full Translation
Subject line: 'On behalf of Taiwan Life Insurance — Announcement of Approved Investment in The Resolute Fund VII, L.P.' Interpretive context: CTBC Financial Holding Co. (2891) is filing this material disclosure as the parent entity acting on behalf of its life insurance subsidiary, Taiwan Life Insurance. The announcement states that an investment in The Resolute Fund VII, L.P. — a private limited partnership, likely a closed-end private equity or alternative asset fund — has received the requisite regulatory approval. Under Taiwan's Insurance Act and FSC rules, insurance companies must obtain pre-approval for certain categories of overseas or alternative investments; this filing signals that approval has been secured and the investment may proceed. [Body not available — subject line only. See MOPS for full announcement.]